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Highlights 
 Enhanced sensitivity consistent with generalized hyperalgesia was observed  
 Acute back pain includes four subgroups with sensitivity and modulation profiles 
 Various factors including sleep and alcohol explain some variation in presentation 
 
Abstract 
Generalised hyperalgesia and impaired pain modulation are reported in chronic low 
back pain (LBP). Few studies have tested whether these features are present in the acute-
phase. This study aimed to test for differences in pain presentation in early-acute LBP and 
evaluate the potential contribution of other factors to variation in sensitivity. Individuals 
within two weeks of onset of acute LBP (N=126) and pain-free controls (N=74) completed 
questionnaires related to their pain, disability, behaviour and psychological status before 
undergoing conditioned pain modulation (CPM) and pain threshold (heat, cold and pressure) 
testing at the back and forearm/thumb. LBP participants were more sensitive to heat and cold 
at both sites and pressure at the back than controls, without differences in CPM. Only those 
with high-pain (numerical rating scale, NRS≥4) were more sensitive to heat at the forearm 
and pressure at the back. Four subgroups with distinct features were identified: “high 
sensitivity”, “low CPM efficacy”, “high sensitivity/low CM efficacy”, and “low 
sensitivity/high CPM efficacy”. Various factors such as sleep and alcohol were associated 
with each pain measure. Results provide evidence for generalised hyperalgesia in many, but 
not all, individuals during acute LBP, with variation accounted for by several factors. 
Specific pain phenotypes provide candidate features to test in longitudinal studies of LBP 
outcome. 
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Perspective: Sensory changes indicative of increased/decreased central processing of pain 
and nociceptive input presented differently between individuals with acute low back pain and 
were related to factors such as sleep and alcohol. This may underlie variation in outcome and 
suggest potential for early identification of individuals with poor long-term outcome. 
Keywords: Generalised hyperalgesia; localised hyperalgesia; conditioned pain modulation 
(CPM); central sensitisation; peripheral sensitisation; low back pain (LBP). 
1. Introduction 
Low back pain (LBP) is the leading cause of disability worldwide,
109
 costing well 
over $100 billion a year in the USA alone.
5
 Treatment effects remain small, which is 
generally explained by the multi-factorial nature of long-term pathophysiological changes, 
mediation by peripheral and/or central nervous system sensitisation, and interaction between 
biological and psychosocial features.
26
 The mechanisms responsible for pain sensitisation,
32, 
99, 116
 and the relative contribution of peripheral and central changes to generation and/or 
persistence of LBP are major targets of research. Most work has investigated individuals with 
chronic pain.
7, 16, 30, 76, 85
 It remains unclear how sensory changes present during an acute LBP 
episode. 
Enhanced nociceptive sensitivity commonly follows injury through activation and 
sensitisation of peripheral nociceptive neurons by inflammatory mediators
21
 that trigger a 
cascade of internal events, leading to depolarisation, delayed repolarisation and lowering of 
the threshold for action potential firing.
60
 Sensitisation begins rapidly and is protective.
100
 If 
noxious stimuli or inflammation persist, maladaptive physiological changes can occur (e.g. 
cytokine mediated up-regulation of ion channels and excitatory receptors) that contribute to 
the maintenance of nociceptor discharge.
43, 115
 This “peripheral” sensitisation induces 
hyperalgesia at the injury site (primary hyperalgesia).
93, 116
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Sensitivity can also spread to undamaged tissues surrounding (secondary 
hyperalgesia) and remote (generalised hyperalgesia) to the injured site, even after the initial 
injury has healed. This sensitivity is mediated by changes in the central processing of 
nociceptive information rather than extension of the area of peripheral 
damage/inflammation.
51, 116
 Secondary hyperalgesia is mediated at the spinal cord whereas 
generalised hyperalgesia is thought to be mediated further upstream.
13, 30, 65, 71
 Both forms of 
hyperalgesia characterise many chronic pain states.  
Localised (primary and/or secondary hyperalgesia) and generalised hyperalgesia are 
common in chronic LBP. Lower pain thresholds to cutaneous heat,
23, 57, 85
 cold,
23, 38
 and 
mechanical stimuli
16, 30, 75
 at (or near) injured and non-injured sites have been reported. Brain 
imaging in chronic LBP reveals activation patterns similar to fibromyalgia, a condition 
characterised by generalised mechanical hypersensitivity.
30
 Conditioned pain modulation 
(CPM) reflects the capacity of endogenous pain modulatory systems to enhance or diminish 
pain.
117
 With normal CPM functioning, painful stimuli reduce pain from noxious stimuli in 
another body region.
64
 Various chronic pain conditions
2, 41, 81, 108
 including chronic LBP
17, 68
 
have been associated with lesser descending nociceptive inhibition or greater nociceptive 
facilitation, but it is not clear whether these changes are a precursor to chronicity or develop 
over time.
59
 Hyperalgesia and deficient CPM have also been linked to various demographic, 
sleep-related
34, 96
 and psychological
27, 28, 69
 factors, many of which are common in chronic 
LBP.
38
 
Our overall objective was to test for evidence of localised and generalised 
hyperalgesia during an acute LBP episode. This study aimed to: (i) compare a suite of pain 
measures (at the back [pain site] and forearm/thumb [remote site]) between pain-free controls 
and people within two weeks of onset of an acute LBP episode; (ii) compare pain measures 
between participants with low- and high-level pain, iii) identify potential subgroups with 
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similar features, and (iv) evaluate the potential contribution of demographic, behavioural and 
psychological factors to variation in pain measures. 
 
2. Methods 
2.1 Participants 
One hundred and twenty-six people in an acute episode of LBP (62 M, 64 F) aged 
29±8 (mean±SD) years and 74 pain-free controls (29 M, 45 F) aged 27±7 years participated 
in the study. Participants were recruited through advertisements around the university and 
local community, social media, and via a participant recruitment agency. Ethical clearance 
was obtained from the Institutional Medical Research Ethics Committee. All participants 
provided informed consent and procedures were conducted in accordance with the 
Declaration of Helsinki. 
LBP participants were recruited and assessed within two weeks of onset of an acute 
episode of LBP that was preceded by at least one month without pain. A LBP episode was 
defined as pain that had lasted longer than 24 hours, caused functional limitation, and caused 
them to seek or seriously consider medical or allied health intervention. They were included 
if they continued to experience pain and disability in the week prior to assessment (see 
below). Participants were excluded from either group if they had known or suspected serious 
spinal pathology (e.g. fracture, inflammatory/infective spinal disease, cauda equine 
syndrome, metastasis and neurological disorders). Participants were also excluded if they 
were less than 18 or more than 50 years old, had major pain or injury to other body regions in 
the previous 12 months, or had other major diseases or disorders (e.g. chronic renal/endocrine 
disorders).  
On arrival at the assessment session participants were asked to rate their “average” 
level of LBP over the last week using a numerical rating scale (NRS) anchored with “no 
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pain” at 0 and “worst pain imaginable” at 10. Pain-related disability was assessed using the 
Roland Morris Disability Questionnaire (RMDQ),
91
 which is a self-administered 
questionnaire consisting of 24 items associated with physical functions likely to be affected 
by LBP. An item receives a score of 1 if it is applicable to the respondent or a score of 0 if it 
is not, with a total score range of 0 (no disability) to 24 (severe disability). Potential control 
participants who reported a score >0 on the NRS and/or RMDQ were excluded from the 
study. Potential LBP participants who reported pain of <1 on the NRS and/or a score of <1 on 
the RMDQ in the past week were excluded from the study.  
2.2 Categorisation of participants 
Participants were categorised in two ways: 1) those with (LBP) and without LBP 
(controls), and 2) those with moderate-to-severe LBP (NRS ≥4, “high-pain”), those with mild 
LBP (NRS <4 but >1, “low-pain”), and controls. Six LBP participants could not be 
categorised further (high- or low-pain) because their pain level was unclear. The NRS cut-off 
used to distinguish between moderate-to-severe and mild LBP is based on those reported by 
Boonstra et al.
10
  
2.3 Procedures 
Participants completed a series of online questionnaires related to their general health, 
demographics, psychological status and sleep behaviours within 24 hours of their laboratory 
assessment. Pain thresholds in response to pressure (pressure pain threshold: PPT), heat (heat 
pain threshold: HPT) and cold (cold pain threshold: CPT) were measured in sequence before 
assessing CPM. 
2.3.1 Questionnaires 
General health and demographic variables: Age, sex, co-morbidities, and self-
reported body mass index (BMI: weight [kg] divided by the squared height) were collected. 
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Participants reported smoking history (current/previous smoker), alcohol habits (frequency 
and amount consumed), and whether they had experienced previous LBP (yes/no). 
Psychological variables: Psychological measures were selected based on three 
domains of relevance in LBP: cognitive (expectations, beliefs and perceptions’ concerning 
pain),
9, 37, 61, 63
 emotional (distress, anxiety and depression),
82
 and behavioural (coping, pain 
behavior and activity/activity avoidance).
37, 61, 63
 
The 20-item Centre for Epidemiological Studies of Depression Scale (CES-D)
87
 was 
used to assess depressive symptoms in the past week. Both total CES-D score (range 0–60) 
and whether they are experiencing clinical depressive symptoms, defined as a total score 
greater than 15,
58
 were considered in the analysis. Thoughts and feelings related to pain 
suggestive of catastrophic cognitions were measured with the valid and reliable 13-item Pain 
Catastrophizing Scale (PCS).
79
 The PCS yields a total score of 0–52, as well as three subscale 
scores of magnification (“I become afraid that the pain will get worse”), rumination (“I worry 
all the time whether the pain will end”) and helplessness (“I feel I can’t go on”). Individual 
component and total PCS scores were used for analyses. The Fear Avoidance Beliefs 
Questionnaire (FABQ) was used to assess fearful and avoidant behaviours related to physical 
activity (FABQ-PA: 5 items, range 0–66) and work (FABQ-W: 11 items, range 0–66) owing 
to the participants’ LBP, with higher scores indicating higher levels of fear-avoidance 
beliefs.
111
 Unemployed participants were removed from the final FABQ-W dataset. The 10-
item Pain Self-Efficacy Questionnaire (PSEQ) was used to quantify the confidence LBP 
participants had in performing activities while in pain
70
 with higher scores reflecting stronger 
pain-specific self-efficacy beliefs.  
Sleep variables: Sleep duration and quality were assessed with the Pittsburgh Sleep 
Quality Index (PSQI). The 19-item questionnaire evaluates global sleep complaints along 
seven dimensions, including subjective sleep quality, sleep duration and latency (time taken 
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to fall asleep), and the frequency and severity of specific sleep-related complaints in the 
previous month.
12
 Scores from each dimension (range: 0–3) are individually reported as 
component scores and summed to derive a sleep quality maximum score of 21; higher scores 
reflect greater sleep complaints. A PSQI score of 5 or higher is considered to indicate poor 
sleep.
12
 The PSQI and its psychometric properties have been validated in various populations 
including those with insomnia.
4, 12, 14
 For analyses we used self-reported hours of actual sleep, 
five individual component (sleep disturbance, sleep latency, daytime dysfunction, sleep 
efficiency, and use of sleep medication) and global PSQI scores, and whether they are 
experiencing poor sleep quality (PSQI>5).  
2.3.2 Pain thresholds 
Pain thresholds were assessed at two anatomical locations: (1) lower back (local) – 
site of “most” pain on palpation in LBP participants or at a fixed site approximately 5 cm 
rostral (towards the head) and lateral to the centre of the lumbo-sacral junction divided 
randomly between the left and right side of the body in control participants, and (2) 
thumb/forearm (remote) – thumbnail (PPT) and proximal volar aspect of the forearm (HPT 
and CPT) on the opposite side of the body to that used to assess pain thresholds at the lower 
back. 
To assess PPT, a pressure algometer (Somedic A/B, Stockholm, Sweden) with a 1-cm 
disc-shaped probe head was applied three times at each location. Pressure was increased at a 
rate of ~40 kPa/s. Participants indicated when the stimulus changed from one of pressure to 
one of pain
103
 and a mean score in kPa was calculated. Thermal pain thresholds were assessed 
using a Thermal Sensory Analyzer (TSA 2001, Medoc, Israel) system with a 30 x 30 mm 
Peltier contact probe. Participants received a continuously ascending or descending stimulus 
which started at 30°C and either increased (cut-off 52°C) or decreased (cut-off 0°C) at a rate 
of 0.7°C/s. Participants indicated with a button press when the sensation of heat/cold became 
Page 8 of 51
9 
 
one of pain
103
 and the stimulus returned to baseline (30°C) at a rate of 10°C/s. Five trials 
were performed at each site (back and forearm) for each test (HPT and CPT), separated by an 
inter-stimulus interval of 10 s. The mean temperature was calculated from the final three 
trials.
84
 
2.3.3 Conditioned pain modulation 
The CPM paradigm was based on our previous work validating the use of PPT as a 
test stimulus (TS) and the lower back as an application site for either the TS or conditioning 
stimulus (CS: noxious contact heat).
47
 Four body regions were selected for testing to explore 
variation in CPM magnitude at different body sites
84
 and whether application of the TS/CS to 
the painful region in LBP participants affects the CPM response: (1) lower back (site of pain 
or a standardised site for controls [see above]), (2) forearm (TS - proximal region of the 
muscle belly of extensor carpi radialis longus; CS - proximal volar aspect), and (3) 
thumbnail. Trials were conducted in three test blocks of different TS and CS arrangements in 
random order: 
(1) TS – lower back, CS – contralateral forearm  
(2) CS – lower back, TS – contralateral forearm and thumb 
(3) CS – forearm (ipsilateral to lower back site), TS – contralateral forearm and thumb 
 CPM was assessed approximately 20 min after assessment of pain thresholds. In each 
block, the TS was first applied alone and then reapplied concomitantly with the CS 30 s after 
onset. The CS was maintained until all TS measurements had been completed (~60 s). A 15-
min rest was enforced between blocks to eliminate any unresolved CPM effects.
113
  
PPT was performed in an identical way to that outlined above (section 2.3.2) for the 
TS. The CS was noxious contact heat, delivered by a computerised stimulation device (TSA 
2001 system with a 30 x 30 mm Peltier contact probe). Unlike limb immersion techniques 
(e.g. hand immersion in painfully hot or cold water), contact heat enabled application of a CS 
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to the back. Target CS temperature was set at 1°C above the participant’s HPT (as 
determined earlier) for each test site. During CPM testing, the CS was applied at an initial 
temperature of 30°C and rose by 0.7 °C/s to the predetermined temperature. Temperature was 
returned to baseline at 7°C/s after completion of TS measurements. At three time-points 
during exposure to the CS (0 s, 30 s, and just prior to cessation of the CS – after the last TS 
recording), participants reported the pain intensity caused by the CS on a 101 point numerical 
rating scale (101-NRS) anchored with “no pain” at 0 and “worst pain imaginable” at 100. 
Some participants were unable to tolerate the target CS during CPM trials, so the CS was 
reduced at 0.5°C increments until the reported pain scores were below “80” on the 101-NRS. 
If the reported pain in response to the CS was less than “45” on the 101-NRS before 
application of the TS (30 s after commencement of the CS), the temperature was increased 
until pain exceeded “45”. This “revised” temperature was then used for all remaining CPM 
trials that involved the same CS test site unless further modifications were required (i.e. 
increase or decrease temperature). This procedure ensured the CS was safe and sufficiently 
intense to induce CPM over a short application time. 
The CPM response was calculated as the difference between the TS scores obtained 
before and during the CS.
119
 A higher TS score during the CS than baseline indicated pain 
inhibition (expressed as a positive value). A lower TS scores during the CS than baseline 
indicated pain facilitation (negative value).
117, 118
 
2.4 Statistical analysis 
Questionnaire data were compared between the control and LBP groups, and between 
the low-pain (NRS<4) and high-pain (NRS≥4) groups using chi-squared (categorical 
variables) or independent t-tests (continuous variables). Data that were not normally 
distributed (e.g. pain threshold and CPM measures were skewed [Kolmogorov-Smirnov test: 
p<0.05]) were log-transformed before further analysis. Because many CPT values were 
Page 10 of 51
11 
 
allocated a zero score (pain threshold beyond the temperature cut-off limit), no suitable 
transformation method achieved a normal distribution, and nonparametric tests (i.e. Mann-
Whitney U test, Kruskal-Wallis ANOVA and logistic regression) were used with raw CPT 
values. Pain thresholds and CPM values for each anatomical arrangement were compared 
between LBP and controls using independent t-tests (log-transformed PPT, HPT and CPM) 
or Mann-Whitney U tests (raw CPT values). Univariate ANOVAs/Kruskal-Wallis ANOVAs 
(group [3 levels] x PPT/HPT/CPT/CPM) were then used to explore differences between the 
high-pain, low-pain and control groups for PPT, HPT, CPT and CPM for each test 
site/stimuli arrangement separately. Bonferroni (PPT, HPT and CPM) and multiple 
comparisons of mean ranks (CPT) methods were used for post-hoc analysis.  
For investigation of potential LBP subgroups, sensory data (PPT, HPT, CPT and 
CPM) were entered into a principal component analysis (PCA). PCA reduces the 
dimensionality of the original data set by generating new independent variables, called 
principal components (PC), to summarise the features of the data.
120
 Most variation in the 
original data set is captured by the first PC, followed by the second PC, and so forth. PCs 
with eigenvalues >1 and/or above a break in the scree plot (“elbow” criterion: value at which 
added dimensions no longer explain the data substantially) were retained.
18, 40
 V-fold cross-
validation was used to validate the optimal number of PCs. Variables with considerable 
influence on each PC were defined as those with a factor loading  ≥±0.5.35 Unbiased 
hierarchical clustering was then carried out on the retained PCs (individual participant t-
scores) to determine the existence of subgroups in acute LBP based on the sensory testing 
results without using a-priori methods or other predefined assumptions. Clustering was 
performed using the publically available Morpheus webtool 
(https://software.broadinstitute.org/morpheus/) using the cosine similarity metric and average 
linkage method. The optimal number of clusters was determined by inspecting the 
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dendrogram/heatmap and limiting the minimum number of participants per cluster to 10. 
Sensory, demographic and basic clinical (pain and disability) data were then compared 
between clusters and controls with appropriate parametric and non-parametric techniques, as 
described above. 
Stepwise linear regression with a strict variable entry/retention criterion of p<0.05 
was used to identify the best combination of factors (health, demographic, psychological and 
sleep) to explain the variation in PPT, HPT and CPM. A stepwise approach was chosen 
because it could create the most parsimonious phenotypic model. In the same manner, we 
used stepwise logistic regression to assess which combination of factors was most predictive 
of a low-CPT (compared to a high-CPT) and facilitatory CPM (compared to inhibitory CPM). 
Low-CPTs and high-CPTs were defined as values in the bottom (high sensitivity) and top 
(low sensitivity) tertiles, respectively. Values that fell within the middle tertile were not 
considered for analysis. Facilitatory CPM represented a negative CPM value whereas 
inhibitory CPM represented a positive CPM value. The overall number of variables included 
in the regression analyses was limited to ensure a sufficient participant-to-variable ratio  (for 
a complete list of variables refer to Table 1) for accurate estimation of regression coefficients, 
standard errors and confidence intervals.
3
 Levels within categorical variables (e.g. sleep 
components: 0–3 levels) that had 10 or fewer participants were not included in the final 
model to avoid type 2 errors. Analyses were performed using Statistica v12 (StatSoft) and 
Stata v14 (Stata Corp). P-values <0.05 were considered statistically significant. 
 
3. Results 
3.1 Group characteristics 
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Participants with and without LBP were similar in terms of sex and current smoking 
status. Table 2 shows differences between groups in the following variables: age, BMI, 
previous/current smoker, previous LBP, sleep hours per night, sleep quality, poor sleeper, 
depressive symptoms, clinically significant depression, and pain catastrophizing (total and 
component scores). For the LBP group, those with low-pain (NRS<4) and high-pain 
(NRS≥4) shared similar characteristics except that average pain intensity (NRS) over the last 
week, disability (RMDQ) and feelings of pain-related helplessness (PCS) were higher in the 
high-pain group (Table 3). 
3.2 Group comparison of pain thresholds and CPM 
Pain thresholds and CPM magnitudes for each group are shown in Figures 1 and 2. 
LBP participants were more sensitive to heat and cold at both the back (t-test: p<0.001) and 
the forearm (p<0.037), and pressure at the back (p=0.002) but not the thumb (p=0.313), than 
controls. Three-way group comparisons showed that both high- and low-pain groups were 
more sensitive to heat at the back (main effect: group – F [2, 192]=9.1, p<0.001; post-hoc: 
p<0.001), but only high-pain sufferers were more sensitive to heat at the forearm (main 
effect: group – F [2, 192]=4.3, p=0.015; post-hoc: p=0.014) and pressure at the back (main 
effect: group – F [2, 192]=4.4, p=0.014; post-hoc: p=0.017), than controls. Although analysis 
of CPT values revealed no significant main effect for group (Kruskal-Wallis, p>0.05), post-
hoc analyses suggested that high-pain participants tended to be more sensitive to cold (pain at 
a higher temperature) at the back than controls (p<0.001). Measures of CPT and PPT at the 
forearm/thumb were not different between the three groups and CPM was not different 
between groups for any stimuli combination. 
3.3 Subgrouping based on pain sensitivity in the LBP group 
PCA derived two PCs (above the “elbow” point: Fig 3) accounting for 45.7% of the 
total variation in the sensory data (Table 4). These PCs can be summarised as representing 
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the dimensions pain threshold (PC1) and CPM (PC2). Hierarchical clustering based on these 
PCs revealed four subgroups with distinct sensory profiles (Fig 4), which were termed 
accordingly: “high sensitivity” (Cluster 1), “ low CPM efficacy” (Cluster 2), “high 
sensitivity/low CPM efficacy” (Cluster 3), and “low sensitivity/high CPM efficacy” (Cluster 
4). Five-way subgroup (clusters 1–4 and controls) comparisons confirmed a main effect for 
subgroup on all pain measures (ANOVA/Kruskal-wallis: all p<0.029, Table 5). When 
compared with controls, the high sensitivity subgroup (Cluster 1) was more sensitive to all 
stimulus types (pressure, heat and cold pain) at both the forearm/thumb and back (post-hoc: 
all p<0.004) and the low CPM efficacy subgroup (Cluster 2) showed lower CPM responses 
for two stimulus arrangements (TS-thumb/CS-forearm, post-hoc: p<0.001; TS-thumb/CS-
back, post-hoc: p=0.002). The high sensitivity/low CPM efficacy subgroup (Cluster 3) was 
more sensitive to all stimulus types at all anatomical locations and displayed lower CPM 
responses for most stimulus arrangements (TS-thumb/CS-back, post-hoc: p=0.021; TS-
back/CS-forearm, post-hoc: p=0.002; TS-forearm/CS-forearm, post-hoc: p=0.056) than 
controls. No sensory differences were found between the low sensitivity/high CPM efficacy 
(Cluster 4) subgroup and controls. Average pain intensity (NRS) over the past week and 
LBP-related disability (RMDQ) were greater in all four LBP clusters than controls but not 
between clusters. Other than age, which was higher in the low CPM efficacy subgroup than 
controls, demographic features were not different between the five groups.  
3.4 PPT: Relationship with pain intensity, general health, demographics, psychological 
status and sleep 
Factors predictive of pressure sensitivity differed between anatomical test sites (see 
Table 6 for statistical outcomes), except that being male was associated with higher PPTs (i.e. 
less sensitive) at both the back and forearm. Greater pain intensity (average over the past 
week) and depressive symptoms were associated with greater pressure sensitivity at the back 
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whereas a lower frequency use of sleep medication (<1 times a week) was associated with 
lower pressure sensitivity at the back. Consumption of five or more alcoholic drinks no more 
than monthly was associated with lower pressure sensitivity at the forearm.  
3.5 HPT: Relationship with pain intensity, general health, demographics, psychological 
status and sleep 
Combined factors related to heat sensitivity are summarised in Table 6. Greater 
average pain intensity over the past week was associated with greater heat sensitivity at both 
anatomical sites. Greater heat sensitivity at the back was also associated with higher pain 
catastrophizing (PCS) whereas lower heat sensitivity was associated with consumption of 
five or more alcoholic drinks in a single drinking session no more than monthly. With respect 
to sleep, findings were complex; a low frequency of sleep disturbance (<1 times a week) but 
frequent daytime dysfunction (1–2 times a week) due to poor sleep and poor sleep efficiency 
(65–75% of “actual” time spent sleeping while in bed) were associated with lower heat 
sensitivity at the back. Other than average pain intensity over the past week, only age was 
associated (positively: i.e. less sensitive) with forearm heat sensitivity. 
3.6 CPT: Relationship with pain intensity, general health, demographics, psychological 
status and sleep 
Combined factors predictive of a low pain threshold (i.e. more sensitive) to cold are 
presented in Table 7. In general, alcohol consumption more frequently and in greater volumes 
were predictive of a low-CPT at both anatomical locations. Further, participants who were 
younger and reported a higher pain intensity over the past week were more likely to report a 
low-CPT when the stimulus was applied to the back than participants who were older and 
reported a lower pain intensity. Although several sleep-related features were predictive of 
cold sensitivity, their relationships were mixed. 
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3.7 CPM: Relationship with pain intensity, health, demographics, psychological status and 
sleep 
Most predictors of facilitatory CPM in which the TS (PPT) was lower (more 
sensitive) during the CS were related to sleep and alcohol behaviours (Table 8). Facilitatory 
CPM was associated with frequent sleep disturbance (≥1 episode a week) for all TS/CS 
configurations and high sleep latency (time taken to fall asleep: >60 min) for the TS-
back/CS-forearm configuration. Interestingly, daytime dysfunction (≥1 episode a week) due 
to poor sleep (TS-thumb, CS-back) was negatively associated with facilitatory CPM for the 
TS-thumb/CS-back configuration. With respect to alcohol, consumption of five or more 
alcoholic drinks on average when drinking was positively associated with facilitatory CPM 
for some TS/CS configurations (TS-forearm, CS-forearm; TS-forearm, CS-back; TS-back, 
CS-forearm), but negatively associated with other configurations (TS-thumb, CS-forearm; 
TS-thumb, CS-back). Frequency of alcohol consumption was also associated with facilitatory 
CPM when stimuli were applied to the upper limbs. Other positive predictors of facilitatory 
CPM included being male, being a past/present smoker, and having greater LBP related 
disability. 
 
4. Discussion 
These results point towards enhanced sensitivity to noxious input in many, but not all, 
individuals with acute LBP. Although there was considerable variation in presentation, four 
subgroups could be distinguished. Factors including sleep and alcohol consumption explained 
some variation in sensitivity.  
4.1 Evidence of localised hyperalgesia 
Group comparisons indicated a generally higher sensitivity to noxious input at the 
back to all stimuli in those with acute LBP than controls, and those with high- versus low-
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pain. Related studies provide inconsistent findings. Although Starkweather et al.
102
 reported 
greater sensitivity to pressure and cold, but not heat, at the painful region, the unusually low 
HPT for controls (HPT>44°C
85
) casts some doubt over the latter result. Other evidence of a 
no significant change in localised sensitivity to pressure in individuals with recent “trouble 
with their lower back”74 is compromised by potential inclusion of individuals with sub-
clinical LBP. LeResche et al.
57
 observed localised hyperalgesia to cold but not heat in chronic 
LBP, but not in LBP of <6 weeks. Our detection of enhanced sensitivity to all stimuli might 
be explained by our larger sample size, strict criteria for symptom severity, and early analysis 
time point before resolution of early inflammatory changes that could mediate peripheral 
sensitisation.  
Elevated pressure pain sensitivity only at the back in acute LBP concurs with previous 
work
102
 that explained this difference as a consequence of sensitisation of local deep tissues. 
Hyperalgesia to pressure can depend on sensitisation of muscle/tendon nociceptors,
44, 48
 as 
evidenced by the observation of hyperalgesia to blunt pressure induced by chemical 
stimulation of the erector spinae muscle but not overlying fascia and subcutis, despite greater 
tonic pain induced by chemical stimulation of the latter two tissues.
95
 Although the edges of 
our testing instrument could excite cutaneous nociceptors, the role of cutaneous nociceptors 
in pain evoked by blunt pressure is minimal.
33, 106
 Our finding that elevated pressure 
sensitivity was restricted to the area of LBP could be explained by peripheral sensitisation 
within deep somatic tissues and/or a central component (i.e. hyperalgesia of non-injured 
tissues impacted by the probe).   
4.2 Evidence of generalised hyperalgesia 
Sensitivity to heat and cold at both the affected and distant (forearm) body sites in 
acute LBP suggests a generalised state of enhanced sensitivity to thermal stimuli, indicative 
of central processes. Of two studies in acute LBP, one reported generalised hyperalgesia to 
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cold but not heat,
102
 and the other reported a no difference.
38
 Mixed findings from chronic 
LBP studies show generalised hyperalgesia to cold and heat,
23
 cold only,
38
 pressure
75
 or 
none.
7
 Inconsistency between results from small samples may be compounded by 
heterogeneity of participants within and between studies, with potential for different pain 
phenotypes.
30, 92
 A recent study showed that chronic LBP patients presenting with non-
mechanical pain (ill-defined, non-remitting, spontaneous) had lower wrist CPT than those 
with mechanical pain (anatomically defined, eases with specific postures/movements), who 
had similar profiles (CPT/PPT) to pain-free controls.
76
 Others have also reported sensory 
features consistent with central sensitisation only within a subgroup of chronic LBP.
99
 No 
studies have considered similar subgroups in acute LBP. 
Our data revealed generalised sensitivity more commonly in individuals with high-
pain. This has two possible interpretations. First, that greater central sensitisation is 
characterised by greater and more widespread sensitivity. Second, that the spread of 
sensitivity to remote uninjured areas depends on the severity of local symptoms. Although 
generalised hyperalgesia is thought to develop as a consequence of central changes (e.g. 
increased neuronal responsiveness
6, 114
 and reorganisation of cortical structures and circuits
20, 
25, 30
) secondary to continuous peripheral inputs,
114
 few have studied its involvement in acute 
conditions.
104
 Our data imply some changes present sooner than previously thought during 
acute LBP episodes for some individuals. 
Absence of group differences in remote PPT implies differences in processing of 
different noxious stimuli. Electrophysiological studies have identified thalamic (site for 
modulation and relay of nociceptive signals to the cerebral cortex
1
) neurons that respond 
specifically to noxious heat, cold or pressure, and others to a combination of these stimuli.
11, 
19, 55, 56
 Further, different noxious stimuli can activate similar brain regions with different 
patterns of activation
15, 19
 or different brain regions with similar patterns.
105
 Our observation 
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of generalised hyperalgesia isolated to thermal stimuli could imply domain-specific effects of 
central processing, at least in the very early period. 
Little is known of CPM in the acute context, though recent evidence suggests CPM is 
unaltered in LBP of <6 weeks.
110
 We found no systematic difference in pain modulation 
between groups, but a marked reduction in some (Clusters 2 and 3) individuals. Although 
CPM efficacy is lower in some chronic pain populations,
59
 evidence in chronic LBP is 
inconclusive.
17, 68, 86
 Our data imply CPM is a feature of some subgroups of LBP or that CPM 
changes develop later. Whether altered CPM during acute LBP is a precursor to development 
of chronicity requires investigation.  
4.3 Subgroups with different sensory profiles 
 Cluster analyses identified subgroups in acute LBP that were characterised by: high 
sensitivity (Cluster 1); low CPM efficacy (Cluster 2); high sensitivity/low CPM efficacy 
(Cluster 3); or low sensitivity/high CPM efficacy (cluster 4). This could imply different 
underlying pain mechanisms between individuals. Individuals that were more sensitive at the 
painful region were also more sensitive at remote regions to all stimuli. Similar features have 
been identified in chronic LBP patients with signs of central sensitisation.
76, 99
 The addition of 
low CPM efficacy (or facilitatory CPM) in some individuals (Cluster 3) may indicate more 
extensive changes in pain processing within the CNS. A subset of individuals presented with 
low/facilitatory CPM but normal (comparable to controls) pain sensitivity. This may be 
because the pathophysiological processes involved in hyperalgesia and reduced descending 
inhibition are different
66, 80, 112
 or that factors other than pain (e.g. expectation/distraction) 
influence CPM.
31, 72, 84
 The subgroup with similar sensory profiles to controls may indicate 
resilience and greater potential for recovery. 
Identification of subgroups raises important questions. First, what determines the 
development of different pain phenotypes following acute LBP? One potential factor is the 
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nature and/or severity of the pain/injury. Our findings of generalised hyperalgesia limited to 
high-pain participants but no difference in LBP intensity between subgroups (clusters 1–4) 
might suggest a non-linear relationship; a threshold input (intensity/duration) might be 
necessary to trigger central sensitisation. Non-linear relationships between generalised 
hyperalgesia and symptom severity have been reported in other chronic musculoskeletal 
conditions.
2, 46, 104
 Other factors associated with sensitivity and CPM (see below) may 
predispose these responses. Second, do indicators of sensory function in acute LBP resolve or 
persist when the condition becomes chronic, or predispose outcome? Our findings and those 
in chronic LBP
23, 38, 74, 75
 suggest signs of central sensitisation shortly after an episode of LBP 
might predict future pain. Whether this is more common in the subgroup with high sensitivity 
or low CPM efficacy requires longitudinal study. 
4.4 Contribution of other factors to pain sensitivity and CPM 
Variation in pain sensitivity and CPM was related to various factors. Poor sleep was 
associated with greater sensitivity to all stimuli and with facilitatory CPM. This concurs with 
the view that sleep and pain are reciprocally related – pain can lead to poor sleep which in 
turn can elevate pain, as occurs in chronic pain conditions
39, 42, 94
 and sleep deprived 
controls.
22, 49, 78
 Causality is most likely bidirectional. Sleep deprivation reduces pain 
thresholds
49, 78, 96
 and pain inhibition,
101, 107
 and sleep problems exacerbate existing pain and 
predict new-onset pain.
8, 77
 The apparent opposing associations of some sleep components 
with sensitivity/CPM may be partly explained by the complex “u-shaped” relationship sleep 
has with pain and general health factors, e.g., either short or long sleep times are adversely 
associated with both.
45, 62, 97
 Psychological factors can mediate the association between sleep 
and pain,
73, 78, 98
 and conversely, sleep can mediate the relationship between pain and 
depression.
36, 67
 Here, greater local sensitivity to pressure and heat at the back correlated with 
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depressive symptoms (CES-D) and pain catastrophizing (PCS), respectively. These data 
support a dynamic interrelationship between pain, sleep and psychological state.  
Alcohol consumption may also interact in a bidirectional manner – greater pain may 
increase alcohol consumption, which may increase pain.
53, 121
 In our data greater/more 
frequent alcohol consumption was generally associated with lower pain thresholds and 
facilitatory CPM. Although a causal link is biologically plausible,
121
 most sensitivity studies 
focus on acute “dampening” rather than behavioural effects of alcohol, and the association 
between alcohol and LBP remains unclear.
54
 
Relationships between age and pain measures were mixed. Older age was related to 
lower HPT (forearm) and higher CPT (back), but unrelated to PPT and CPM. Although this 
differs from observations of higher thermal pain threshold, lower PPT, and lower/facilitatory 
CPM with age,
29, 52, 89
 our cohort’s narrow age span limits confidence as the upper age was 
below the threshold for somatosensory changes.
50
 With respect to sex, males were less 
sensitive to pressure (local/remote) and experienced facilitatory CPM more frequently. This 
concurs with observations of pressure sensitivity (although thermal sensitivity is also usually 
lower in males)
24, 90
 but not CPM efficacy, which is often lower in females.
83
 This might be 
explained by our lack of control for menstrual cycle (we prioritised assessment relative to 
pain onset), which impacts CPM.
88
 
4.5 Methodological limitations 
Many variables were analysed in this study, which raises the potential for spurious 
findings. Although several features were consistently related to all measures of sensitivity, we 
were concerned that some (e.g. alcohol consumption) related differently to CPM when 
different stimuli configurations were used. Larger and longitudinal studies are needed to fully 
understand the implications of these results. Further, CPM is known to be highly variable. By 
including multiple CPM measures we reduced the potential impact of spurious results. For 
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instance, the CPM measure that did not co-vary with the other four CPM measures, as 
determined in the PCA, was excluded from the final analysis. Finally, the use of stepwise 
regression has some inherent disadvantages that could have resulted in some variables (i.e. 
(health, demographic, psychological and sleep factors) not being included in the final 
stepwise solution despite being independently related to the outcome measure (i.e. sensory 
test). Our primary reason for using this approach was to identify the fewest variables to 
explain the greatest variability in the response to each sensory test. 
4.6 Conclusion 
This is the first study to demonstrate generalised hyperalgesia in early-acute LBP. As 
in chronic LBP, sensory profiles varied between individuals but subgroups with similar 
features were identified. The degree of sensitivity and CPM appears to be impacted by 
various factors such as sleep and alcohol consumption. Longitudinal examination is needed to 
assess the predictive value of specific pain phenotypes on outcome. 
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Figure captions 
Figure 1. Pain thresholds in response to heat, cold and pressure at the forearm/thumb and 
back between: i) low back pain and pain-free control participants, and ii) low back pain 
participants divided into those with high-pain (NRS≥4) and low-pain (NRS<4), and pain-free 
control participants. Box-plots represent median (horizontal line), 25th and 75th percentiles 
(box), and 10th and 90th percentiles (lines outside the box). *p<0.05; **p<0.01; ***p<0.001. 
 
Figure 2. Conditioned pain modulation scores for different test stimulus (TS) and 
conditioning stimulus configurations between: i) low back pain and pain-free control 
participants, and ii) low back pain participants divided into those with high-pain (NRS≥4) 
and low-pain (NRS<4), and pain-free control participants. Descriptions of the box-plots are 
given in Fig 1. *p<0.05; **p<0.01; ***p<0.001. 
 
Figure 3. Scree plot of the principal component extraction showing (dashed lines) the break 
(“elbow”) in the curve, above which is considered to indicate the maximum number of 
principal components to extract. Two principal components were extracted – one less than the 
number at the “elbow” point. 
 
Figure 4. Hierarchical clustering of low back pain individuals based on principal component 
analysis. Results are displayed as a heatmap and dendrogram in which the principal 
component (PC) scores are represented by shades of red (positive) and blue (negative). Each 
row is a PC, and each column is an individual low back pain participant. The dendrogram at 
the top shows group similarities, with four distinct clusters: Cluster 1 – “high sensitivity”, 
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Cluster 2 – “low CPM efficacy”, Cluster 3 – “high sensitivity/low CPM efficacy”, and 
Cluster 4 – “low sensitivity/high CPM efficacy. 
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 Table 1. Variables included in the regression analyses. 
Variable Variable type 
Age (yrs) Continuous 
Sex (male, female) Categorical 
Body mass index (BMI) Continuous 
Current/previous smoker (yes, no) Categorical 
Previous LBP (yes, no) Categorical 
Pain intensity (numerical rating scale: NRS) Continuous 
Disability (Roland Morris Disability Questionnaire: RMDQ) Continuous 
Alcohol consumption (Alcohol Use Disorders Identification Test: AUDIT) 
 
Frequency  (never, <monthly, 2-4 times/m, 2-3 times/w, >4 times/w) Categorical 
Quantity (drinks: 1-2, 3-4, 5-6, 7-9, >10) Categorical 
5+ drinks frequency (never, <monthly, monthly, weekly, daily or almost daily) Categorical 
Sleep quality (Pittsburgh Sleep Quality Index: PSQI) 
 
Total score Continuous 
Sleep hours per night (h) Continuous 
Sleep disturbance (not during the past month, <1 times/w, 1-2 times/w, 3-4 times/w) Categorical 
Sleep latency (<15 min, 16-30 min, 31-60 min, >60 min) Categorical 
Daytime dysfunction (not during past month, <1 times/w, 1-2 times/w, >3 times/w) Categorical 
Sleep efficiency (>85%, 75-84%, 65-74%, <65%) Categorical 
Use of sleep medication (not during past month, <1 times/w, 1-2 times/w, >3 times/w) Categorical 
Depressive symptoms (Centre for Epidemiological Studies Depression Scale: CES-D) Continuous 
Pain catastrophizing (Pain Catastrophizing Scale: PCS) Continuous 
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Table 2. Low back pain (N = 126) and control (N = 74) participant characteristics. 
 
Control 
 
LBP 
 
Characteristic Mean (SD) Range 
 
Mean (SD) Range P-value 
Age (yrs) 27 (7) 18–47 
 
29 (8) 18–50 0.027 
Sex (male, %) 39.2 - 
 
49.2 - 0.170 
BMI (kg/m
2
) 22.7 (4.4) 16.8–43.4 
 
24.1 (3.8) 16.6–39.2 0.021 
Current smoker (%) 2.7 - 
 
7.6 - 0.159 
Previous/current smoker (%) 20.5 - 
 
40.7 - 0.004 
Previous LBP (%) 4.2 - 
 
92.3 - <0.001 
Sleep hours per night (h) 7.4 (1.2) 4–10 
 
6.9 (1.3) 4–10 0.006 
Sleep quality
a
 4.0 (2.3) 0–9 
 
6.5 (3.2) 1–15 <0.001 
Poor sleeper (%)
b
 27.1 -  57.8 - <0.001 
Depressive symptoms
c
 8.6 (6.5) 1–27 
 
13.7 (9.0) 0–39 <0.001 
Clinically sig. depression (%)
d
 15.3 - 
 
34.5 - 0.004 
Pain catastrophizing
e
: 7.5 (9.6) 0–41 
 
13.5 (10.2) 0–49 <0.001 
Rumination 3.0 (3.8) 0–13 
 
4.7 (4.0) 0–16 0.004 
Magnification 1.6 (2.1) 0–9 
 
3.40 (2.7) 0–12 <0.001 
Helplessness 2.9 (4.4) 0–23 
 
5.4 (4.7) 0–21 <0.001 
a
Scored using the 19-item Pittsburgh Sleep Quality Index. Higher scores reflect poorer sleep. 
bInterpreted from the Pittsburgh Sleep Quality Index. A global sum of “6” or greater indicates a “poor” sleeper  
c
Scored using the 20-item Epidemiological Studies of Depression Scale. Higher scores reflect greater 
depressive symptoms.  
d
Interpreted from the Epidemiological Studies of Depression Scale. A global sum of “16” or greater indicates 
clinically significant depressive symptoms. 
e
Scored using the 13-item Pain Catastrophizing Scale. Higher scores reflect greater pain-related catastrophizing. 
Components of the questionnaire include rumination, magnification and helplessness. 
Significant values are in bold font.  
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  Table 3. High- (N = 91) and low-pain (N = 29) participant characteristics.  
 
Low-Pain 
 
High-Pain  
Characteristic Mean (SD) Range 
 
Mean (SD) Range P-value 
Age (yrs) 31 (9) 18–49 
 
29 (8) 18–50 0.290 
Sex (male, %) 55.2 - 
 
48.4 - 0.522 
BMI (kg/m
2
) 24.1 (3.6) 16.9–31.5 
 
23.9 (3.9) 16.6–39.2 0.835 
Current smoker (%) 6.9 - 
 
8.0 - 0.853 
Previous/current smoker (%) 41.4 - 
 
39.8 - 0.878 
Previous LBP (%) 96.4 - 
 
90.9 - 0.342 
Pain intensity
a
 2.5 (0.7) 1–3 
 
5.8 (1.3) 4–9 <0.001 
Disability severity
b
 4.8 (3.3) 1–14 
 
7.0 (4.4) 1–21 0.015 
Sleep hours per night (h) 7.0 (1.2) 4–9 
 
6.9 (1.3) 4–10 0.496 
Sleep quality
c
 6.3 (2.8) 1–12 
 
6.6 (3.3) 1–15 0.644 
Poor sleeper (%)
d
 53.6 -  59.1 - 0.607 
Depressive symptoms
e
 14.8 (10.5) 0–39 
 
13.4 (8.5) 0–37 0.491 
Clinically sig. depression (%)
f
 39.3 - 
 
33.0 - 0.538 
Fear avoidance (work)
g
 12.1 (8.7) 0–27 
 
12.1 (9.8) 0–36 0.998 
Fear avoidance (activity)
h
 13.5 (5.5) 0–24 
 
15.1 (5.5) 0–24 0.165 
Pain self-efficacy
i
 46.1 (10.6) 14–60 
 
44.1 (10.7) 18–60 0.444 
Pain catastrophizing
j
: 10.4 (7.8) 1–34 
 
14.5 (10.8) 0–49 0.060 
Rumination 3.6 (3.1) 0–12 
 
5.0 (4.2) 0–16 0.096 
Magnification 3.1 (2.1) 0–9 
 
3.5 (2.8) 0–12 0.400 
Helplessness 3.7 (3.3) 0–13 
 
5.9 (5.0) 0–21 0.029 
a
Scored on a 0 to 10 numerical rating scale (0 = no pain, 10 = worst pain imaginable) 
b
Scored using the 24-item Roland Morris Disability Questionnaire. Higher scores reflect greater disability. 
c
Scored using the 19-item Pittsburgh Sleep Quality Index. Higher scores reflect poorer sleep. 
dInterpreted from the Pittsburgh Sleep Quality Index. A global sum of “6” or greater indicates a “poor” sleeper  
e
Scored using the 20-item Epidemiological Studies of Depression Scale. Higher scores reflect greater 
depressive symptoms.  
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f
Interpreted from the Epidemiological Studies of Depression Scale. Scores greater than 15 indicate clinically 
significant depressive symptoms. 
g
Scored using the 5-item Fear Avoidance Beliefs Questionnaire-Work. Higher scores indicate higher levels of 
fear-avoidance beliefs related to work. 
h
Scored using the 11-item Fear Avoidance Beliefs Questionnaire-Physical Activity. Higher scores indicate 
higher levels of fear-avoidance beliefs related to physical activity. 
i
Scored using the 10-item Pain Self-Efficacy Questionnaire. Higher scores reflect stronger self-efficacy beliefs 
with respect to performing activities while in pain.  
j
Scored using the 13-item Pain Catastrophizing Scale. Higher scores reflect greater pain-related catastrophizing. 
Components of the questionnaire include rumination, magnification and helplessness. 
Significant values are in bold font. 
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Table 4. Principal component analysis of pain threshold and conditioned pain modulation data in low back pain 
participants.  
Sensory test PC 1 PC 2 PC3 
PPT - thumb 0.67 -0.03 0.17 
PPT - back 0.70 0.06 0.10 
HPT - forearm 0.74 -0.06 -0.36 
HPT - back 0.80 0.03 -0.17 
CPT - forearm -0.73 0.13 0.06 
CPT - back -0.76 -0.01 -0.01 
CPM (TS-thumb/CS-forearm) -0.21 0.69 -0.31 
CPM (TS-forearm/CS-forearm) 0.20 0.55 0.03 
CPM (TS-thumb/CS-back) -0.05 0.67 0.28 
CPM (TS-forearm/CS-back) 0.29 0.05 0.79 
CPM (TS-back/CS-forearm) 0.28 0.50 -0.11 
% of variance 31.9 13.8 9.2 
Cumulative % of variance 31.9 45.7 54.8 
Two of the first three principal components shown were retained (no shading). Variable loading on each 
principal component was considered significant if ≥±0.5 (highlighted in bold). PPT, pressure pain threshold; 
HPT, heat pain threshold; CPT, cold pain threshold; CPM, conditioned pain modulation; TS, test stimulus; CS, 
conditioning stimulus.  
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Table 5. Sensory, clinical and demographic measures for the four low back pain subgroups identified by PCA-based hierarchical clustering and 
the control group. 
Variable 
Cluster 
1: High 
Sensitivi
ty 
(N=34) 
Cluster 2: Low CPM efficacy 
(N=33) 
Cluster 3: 
High 
Sensitivity/L
ow CPM 
Efficacy 
(N=27) 
Cluster 4: Low Sensitivity/High CPM 
Efficacy (N=31) 
Controls 
(N=74) 
Main Effect 
(P) 
Sensory 
 
   
 
 
     PPT – thumb (kPa)
†
 
381.5 
(111.1)** 
594.1 (153.6) 
366.1 
(110.1)** 
535.6 (154.3) 
494.51 
(168.2) 
<0.001 
     PPT – back (kPa)
†
 
359.8 
(153.8)*** 
639.0 (258.8) 
368.0 
(153.0)*** 
661.9 (276) 
607.86 
(239.2) 
<0.001 
     HPT – arm (°C)
†
 
41.5 
(4.0)*** 
46.0 (2.5) 41.7 (3.4)*** 45.8 (1.7) 45.2 (3.1) <0.001 
     HPT – back (°C)
†
 
40.8 
(3.6)*** 
45.9 (3.3) 40.4 (3.9)*** 46.2 (2.1) 45.8 (3.0) <0.001 
     CPT – arm (°C) 
17.9 
(7.1)*** 
5.3 (5.6) 16.4 (7.3)** 6.8 (7.1) 8.9 (8.9) <0.001 
     CPT – back (°C) 
16.7 
(8.7)*** 
4.6 (7.7) 17.8 (7.8)*** 4.6 (8.6) 4.7 (7.3) <0.001 
     CPM (TS-thumb/CS-
arm)
†
 
58.7 (44.5) -48.8 (67.0)*** -17.3 (41.7) 38.3 (58.4) 19.9 (66.8) <0.001 
     CPM (TS-arm/CS-
arm)
†
 
40.5 (42.0) 6.3 (35.9) 4.2 (49.4)
●
 68.0 (78.8) 46.8 (80.1) <0.001 
     CPM (TS-thumb/CS-
back)
†
 
42.5 (52.0) -37.9 (65.1)** -30.8 (68.9)* 50.0 (73.9) 18.3 (77.2) <0.001 
     CPM (TS-arm/CS-
back)
†
 
15.5 (81.9) 49.0 (66.9) 1.2 (67.8) 40.1 (85.3) 41.9 (69.2) 0.028 
     CPM (TS-back/CS-
arm)
†
 
55.2 (47.9) 32.1 (87.5) -2.9 (70.5)** 118.2 (89.6) 72.7 (111.8) <0.001 
Clinical 
 
   
 
 
     Pain intensity (NRS) 
5.1 
(1.7)*** 
5.0 (2.0)*** 5.2 (1.9)*** 4.9 (1.9)*** 0.0 (0.0) <0.001 
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     Disability (RMDQ) 
5.3 
(3.6)*** 
5.8 (4.3)*** 7.3 (4.7)*** 7.9 (4.1)*** 0.0 (0.0) <0.001 
Demographic       
     Age (yrs) 26.8 (7.4) 31.5 (7.1)* 27.3 (9.6) 30.6 (7.7) 26.6 (6.5) 0.006 
     Sex (male, %) 35.3 63.6 40.7 58.1 39.2 0.056 
     BMI (kg/m
2
) 23.1 (3.2) 24.2 (3.9) 24.6 (4.4) 24.7 (3.8) 22.7 (4.4) 0.074 
     Previous/current 
smoker (%) 
35.3 20.3 40.7 38.7 20.5 0.080 
Variables were compared across all four clusters using one-way ANOVAs (continuous variables), Kruskal-Wallis (CPT – arm; CPT – back) or 
chi-squared tests (categorical variables). 
†
P-value is calculated after log-transformation. 
Continuous data described as mean ±SD. Categorical data described as number (%). 
Values in bold font are significantly different from the control group (post-hoc: clusters 1–4 vs control, ●p=0.056; *p<0.05; **p<0.01; 
***p<0.001). 
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Table 6. Association of factors on pain thresholds in response to pressure (PPT) and heat 
(HPT) at the forearm/thumb and back.  
Variable PPT-thumb PPT-back HPT-forearm HPT-back 
Age (yrs) - - 
0.17 (0.03–
0.31)* 
- 
Sex (male, %) 
0.29 (0.15–
0.42)*** 
0.28 (0.15–
0.42)*** 
- - 
Pain intensity (NRS) - 
-0.19 (-0.33– -
0.05)** 
-0.22 (-0.36– -
0.08)** 
-0.23 (-0.38–
0.08)** 
5+ drinks monthly
a
 
0.31 (0.0–
0.52)** 
- - 
0.23 (0.09–
0.44)* 
PSQI: sleep efficiency 65-
75%
b
 
- - - 
0.38 (0.12–
0.65)** 
PSQI: sleep disturbance <1 
times/w
c
 
   
0.36 (0.12–
0.61)** 
PSQI: daytime dysfunction 1-
2 times/w
d
 
- - - 
0.27 (0.04–
0.49)* 
PSQI: sleep med. <1 times/w
e
 - 
0.43 (0.17–
0.68)** 
- - 
CES-D: total score - 
-0.17 (-0.31– -
0.03)* 
- - 
Pain catastrophizing - - - 
-0.17 (-0.31– -
0.02)* 
Overall fit (R
2
) 0.12 0.23 0.07 0.25 
Data represent regression coefficients (95% confidence intervals) of various factors 
demonstrating an association with pressure and heat pain thresholds (log transformed) using 
stepwise linear regression models. Only significant factors are shown (*p<0.05; **p<0.01; 
***p<0.001): 
a
frequency at which 5 or more alcoholic drinks are consumed in a single 
drinking session, 
b
average amount of sleep as a percentage of total time spent in bed per night 
in the last month, 
c
frequency of sleep disturbances in the last month, 
d
frequency of sleep-
related daytime dysfunction experienced in the last month, 
e
frequency of sleep medication 
use to help sleep in the last month. 
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Table 7. Predictors of a low cold pain threshold (bottom tertile: >14.9°C) as opposed to a 
high cold pain threshold (top tertile: <4.4°C) at the forearm and back. 
Variable CPT-forearm   CPT-back 
Age (yrs) -  -0.09 (-0.17– -0.02)* 
Pain intensity (NRS) -  0.32 (0.13–0.50)*** 
≥5 drinksa 3.22 (1.78–4.65)***  - 
Drink freq 2-3 times/w
b
 1.00 (0.08–1.93)*  1.25 (0.18–2.33)* 
5+ drinks monthly
c
 -  -1.46 (-2.84– -0.07)* 
PSQI: sleep hours
d
 0.41 (0.05–0.76)*  - 
PSQI: sleep disturbance ≥1 times/we 4.52 (3.48–5.56)***  4.23 (3.09–5.36)*** 
PSQI: daytime dysfunction ≥1 times/wf -4.93 (-6.31– -3.56)***  -5.34 (-6.85– -3.83)*** 
Somers’ D 0.54  0.66 
Data represent the log odds (95% confidence intervals) for various factors predictive 
(negatively or positively) of a cold pain threshold >14.9°C (low-CPT) based on stepwise 
logistic regression models. Only significant factors are shown (*p<0.05; **p<0.01; 
***p<0.001):
 a
number of alcoholic drinks typically consumed when drinking, 
b
frequency at 
which alcohol is consumed, 
c
frequency at which 5 or more alcoholic drinks are consumed in 
a single drinking session, 
d
average number of hours slept per night in the last month, 
e
frequency of sleep disturbances in the last month, 
f
frequency of sleep-related daytime 
dysfunction experienced in the last month. 
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Table 8. Predictors of facilitatory conditioned pain modulation (CPM value <0) for different 
test stimulus (TS) and conditioning stimulus (CS) configurations. 
 
Stimuli Configuration 
Variable 
TS-thumb/CS-
forearm 
TS-
forearm/CS-
forearm 
TS-
thumb/CS-
back 
TS-
forearm/CS-
back 
TS-
back/
CS-
forea
rm 
Sex (male, %) 
0.41 (0.08–
0.73)* 
- - - 
0.38 
(0.01
–
0.76)
* 
Disability (RMDQ) - 
0.09 (0.01–
0.17)* 
- - - 
Smoke now/ever - - - 
0.53 (0.17–
.89)** 
- 
≥5 drinksa 
-3.20 (-4.37– -
2.02)*** 
3.41 (2.24–
4.60)*** 
-3.28 (-4.37– -
2.19)*** 
3.28 (2.04–
4.52)*** 
2.34 
(0.65
–
4.02)
** 
Drink freq 2-3 times/w
b
 - 
0.77 (0.04–
1.49)* 
- - - 
5+ drinks <monthly
c
 
-0.68 (-1.29– -
0.06)* 
- - - - 
PSQI: sleep latency >60 
min
d
 
- - - - 
1.15 
(0.10
–
2.19)
* 
PSQI: sleep disturbance 
≥1 times/we 
4.40 (3.65–
5.15)*** 
3.88 (3.09–
4.67)*** 
4.20 (3.45–
4.95)*** 
4.23 (3.45–
5.01)*** 
7.83 
(6.98
–
8.68)
*** 
PSQI: daytime 
dysfunction ≥1 times/wf 
- - 
-4.02 (-4.99– -
3.05)*** 
- - 
Somers’ D 0.40 0.40 0.22 0.35 0.42 
Data represent the log odds (95% confidence intervals) for various factors predictive 
(negatively or positively) of facilitatory CPM based on stepwise logistic regression models. 
Only significant factors are shown (*p<0.05; **p<0.01; ***p<0.001): 
a 
number of alcoholic 
drinks typically consumed when drinking, 
b
frequency at which alcohol is consumed, 
c
frequency at which 5 or more alcoholic drinks are consumed in a single drinking session, 
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d
average time taken to fall asleep per night in the last month, 
e
frequency of sleep disturbances 
in the last month, 
f
frequency of sleep-related daytime dysfunction experienced in the last 
month. 
 
 
Page 48 of 51
49 
 
Figure 1. 
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Figure 2. 
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Figure 3. 
 
 
Figure 4. 
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